kevin.strange@novobiosciences.com

Pioneering new therapies in regenerative medicine.
  • Home
  • Technology
    • APPROACH
    • PIPELINE
  • Team
    • SENIOR MANAGEMENT
    • ADVISORY BOARD
  • Media & Press
  • Contact

Pioneering new therapies in regenerative medicine.
Close
  • Home
  • Technology
    • APPROACH
    • PIPELINE
  • Team
    • SENIOR MANAGEMENT
    • ADVISORY BOARD
  • Media & Press
  • Contact

Novo Biosciences Receives Federal Grant to Advance Potential Heart Drug

September 7, 2017 0 0 3.4 0
Novo Biosciences Receives Federal Grant to Advance Potential Heart Drug

Novo Biosciences Inc. has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of MSI-1436 as a potential regenerative medicine...

Read more

Drug Could Regenerate Damaged Tissue After a Heart Attack, Study Suggests

March 14, 2017 0 0 4.3 0
Drug Could Regenerate Damaged Tissue After a Heart Attack, Study Suggests

US researchers claim to have identified a groundbreaking drug that could restore heart muscle function following a heart attack.  A new study describes how MSI-1436, a naturally occurring compound, regenerates heart muscle tissue in zebrafish and...

Read more

Novo Biosciences Scientists Receive Patent to Develop Molecule that Could Repair Heart Tissue

August 23, 2016 0 0 0
Novo Biosciences Scientists Receive Patent to Develop Molecule that Could Repair Heart Tissue

A federal patent has been awarded to scientists at Novo Biosciences, a step that will allow research to proceed on a molecule that shows promise in helping heart tissue regenerate after a heart attack.

Read more
© Copyright 2019 Novo Biosciences Inc.   All rights reserved.